India to Poland: Topotecan Export Trade Route
India has recorded 67 verified shipments of Topotecan exported to Poland, representing a combined trade value of $1.1M USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $16.7K USD. The leading Indian exporter is INTAS PHARMACEUTICALS LIMITED, which accounts for 80% of total export value with 48 shipments worth $893.0K USD. On the buying side, Accord Healthcare Polska Sp. z o.o. is the largest importer in Poland with $257.0K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Poland Topotecan corridor is one of India's established pharmaceutical export routes, with 67 shipments documented worth a combined $1.1M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 80% of all export value, reflecting the consolidated nature of India's topotecan manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $16.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with topotecan's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 13.2%, placing it at rank #16 among India's top topotecan export destinations globally.
On the import side, key buyers of Indian topotecan in Poland include Accord Healthcare Polska Sp. z o.o., ACCORD HEALTHCARE POLSKA SP. Z O.O., TO THE ORDER and 10 others. Accord Healthcare Polska Sp. z o.o. is the single largest importer with 6 shipments valued at $257.0K USD.
Route Characteristics
- Average transit26 days
- Peak seasonQ1
- Primary modeSea freight
- Top portMUNDRA SEA (INMUN1)
Market Position
- Global rank#16
- Annual growth+13.2%
- Demand growth+13.5%
- Regulatory ease81/100
Top 10 Indian Topotecan Exporters to Poland
Showing top 10 of 2 Indian suppliers exporting Topotecan to Poland, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED Avg $18.6K per shipment | 48 | $893.0K | 79.9% |
| 2 | INTAS PHARMACEUTICALS LIMITED Avg $11.8K per shipment | 19 | $225.1K | 20.1% |
This table shows the top 10 of 2 Indian companies exporting topotecan to Poland, ranked by total trade value. The listed exporters are: INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED . INTAS PHARMACEUTICALS LIMITED is the dominant supplier with 48 shipments worth $893.0K USD, giving it a 80% market share.
Top 10 Topotecan Importers in Poland
Showing top 10 of 13 known buyers in Poland receiving Topotecan shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian topotecan in Poland include Accord Healthcare Polska Sp. z o.o., ACCORD HEALTHCARE POLSKA SP. Z O.O., TO THE ORDER, ACCORD HEALTHCARE POLSKA SP. Z.O.O. , ACCORD HEALTHCARE POLSKA SP. Z.O.O., among 13 total buyers. The largest importer is Accord Healthcare Polska Sp. z o.o., accounting for $257.0K USD across 6 shipments — representing 23% of all topotecan imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | Accord Healthcare Polska Sp. z o.o. | 6 | $257.0K | 23.0% |
| 2 | ACCORD HEALTHCARE POLSKA SP. Z O.O. | 7 | $238.4K | 21.3% |
| 3 | TO THE ORDER | 12 | $139.9K | 12.5% |
| 4 | ACCORD HEALTHCARE POLSKA SP. Z.O.O. | 13 | $123.2K | 11.0% |
| 5 | ACCORD HEALTHCARE POLSKA SP. Z.O.O. | 7 | $113.7K | 10.2% |
| 6 | ACCORD HEALTHCARE POLSKA SP. Z O.O. | 2 | $67.0K | 6.0% |
| 7 | ACCORD HEALTHCARE POLSKA SP. Z O.O | 5 | $52.5K | 4.7% |
| 8 | ACCORD HEALTHCARE POLSKA SP Z O O | 7 | $44.7K | 4.0% |
| 9 | Accord Healthcare Polska Sp. z o.o. | 3 | $27.2K | 2.4% |
| 10 | ACCORD HEALTHCARE POLSKA SP ZOO MAGAZYN IMPORTERA UL LUTOMIERSKA | 2 | $24.9K | 2.2% |
Showing top 10 of 13 Topotecan importers in Poland on this route.
Top 10 Topotecan Formulations Imported by Poland
Showing top 10 of 45 product formulations shipped on the India to Poland Topotecan route, ranked by trade value
Poland imports a wide range of topotecan formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMA DRUGS & MEDI TOPOTECAN INJ1MG/ML, — accounts for $111.4K USD across 9 shipments. There are 45 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMA DRUGS & MEDI TOPOTECAN INJ1MG/ML, | 9 | $111.4K | 10.0% |
| 2 | PHA.DRU & MEDI, TOPOTECAN INJ1MG/ML,4ML | 2 | $106.3K | 9.5% |
| 3 | PHARMA DRUG&MED: TOPOTECAN INJ1MG/ML,4MLRTU Each mL contains Topotecan Hydrochloride eq. toTopotecan. 1.0 mg | 1 | $97.2K | 8.7% |
| 4 | PHARMA DRUG&MED:TOPOTECAN RTU,1MG/ML,4ML | 2 | $90.9K | 8.1% |
| 5 | PHARMA DRUG&MED: TOPOTECAN INJ1MG/ML,4MLRTU Each mL contains Topotecan Hydrochloride eq. to.Topotecan..1.0 mg | 1 | $62.1K | 5.6% |
| 6 | PHARMA DRUGS & MEDI TOPOTECAN INJ1MG/ML,4ML RTU AS PER INVOICE | 1 | $61.3K | 5.5% |
| 7 | PHR DRUGS & MEDI TOPOTECAN INJ1MG/ML,4ML | 1 | $44.9K | 4.0% |
| 8 | PHARMA DRUG&MED:TOPOTECAN INJ1MG/ML,4MLR | 2 | $37.4K | 3.3% |
| 9 | PHARMACEUTICAL DRUGS AND MEDICINE-TOPOTECAN RTU,1MG/ML,4ML(ACCORD-ROMANIA Each mL containsTopotecan Hydrochloride eq.(AS | 2 | $32.4K | 2.9% |
| 10 | PHARMA DRUG&MED:TOPOTECAN INJ1MG/ML,4ML | 1 | $30.3K | 2.7% |
Showing top 10 of 45 Topotecan formulations imported by Poland on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 77%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
MUNDRA SEA (INMUN1) handles the highest volume with 25 shipments. Transit time averages 26 days by sea.
Market Dynamics
India's topotecan exports to Poland are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 48 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Poland benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $16.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as pha.dru & medi, topotecan inj1mg/ml,4ml and pharma drug&med: topotecan inj1mg/ml,4mlrtu each ml contains topotecan hydrochloride eq. totopotecan. 1.0 mg, suggesting that buyers in Poland tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, Accord Healthcare Polska Sp. z o.o. is the largest importer with 6 shipments worth $257.0K USD — representing 23% of all topotecan imports from India on this route. A total of 13 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $1.1M
- Avg. Shipment
- $16.7K
- Suppliers
- 2
- Buyers
- 13
- Transit (Sea)
- ~26 days
- Annual Growth
- +13.2%
Other Topotecan Routes
Unlock the Full India to Poland Topotecan Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 67 shipments on this route.
Frequently Asked Questions — India to Poland Topotecan Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Topotecan to Poland?
The leading Indian exporters of Topotecan to Poland are INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED . INTAS PHARMACEUTICALS LIMITED holds the largest market share at approximately 80% of total trade value on this route.
Q What is the total value of Topotecan exports from India to Poland?
India exports Topotecan to Poland worth approximately $1.1M USD across 67 recorded shipments. The average value per shipment is $16.7K USD.
Q Which ports does India use to ship Topotecan to Poland?
The most active port of origin is MUNDRA SEA (INMUN1) with 25 shipments. Indian exporters primarily use sea freight for this route, with 77% of shipments going by sea and 24% by air.
Q How long does shipping take from India to Poland for Topotecan?
The average transit time for Topotecan shipments from India to Poland is approximately 26 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Poland Topotecan trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 13.2% with demand growth tracking at 13.5%. The route is ranked #16 among India's top Topotecan export destinations globally.
Q How many suppliers are active on the India to Poland Topotecan route?
There are currently 2 active Indian suppliers exporting Topotecan to Poland. The market is moderately concentrated with INTAS PHARMACEUTICALS LIMITED accounting for 80% of total shipment value.
Q Who are the main importers of Topotecan from India in Poland?
The leading importers of Indian Topotecan in Poland include Accord Healthcare Polska Sp. z o.o., ACCORD HEALTHCARE POLSKA SP. Z O.O., TO THE ORDER, ACCORD HEALTHCARE POLSKA SP. Z.O.O. , ACCORD HEALTHCARE POLSKA SP. Z.O.O.. Accord Healthcare Polska Sp. z o.o. is the largest buyer with 6 shipments worth $257.0K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Poland export trade corridor identified from Indian Customs (DGFT) records for Topotecan.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 13 importers in Poland matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 67 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
67 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists